CMH Stock Overview
Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Chordate Medical Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.057 |
| 52 Week High | kr0.50 |
| 52 Week Low | kr0.048 |
| Beta | 0.86 |
| 1 Month Change | -15.81% |
| 3 Month Change | -67.50% |
| 1 Year Change | -88.00% |
| 3 Year Change | -92.69% |
| 5 Year Change | -94.96% |
| Change since IPO | -99.59% |
Recent News & Updates
Shareholder Returns
| CMH | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 2.2% | 1.0% | 1.1% |
| 1Y | -88.0% | -8.9% | 8.6% |
Return vs Industry: CMH underperformed the Swedish Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: CMH underperformed the Swedish Market which returned 8.6% over the past year.
Price Volatility
| CMH volatility | |
|---|---|
| CMH Average Weekly Movement | 17.9% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: CMH's share price has been volatile over the past 3 months.
Volatility Over Time: CMH's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3 | Anders Weilandt | www.chordate.com |
Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. Chordate Medical Holding AB (publ) was incorporated in 2014 and is based in Kista, Sweden.
Chordate Medical Holding AB (publ) Fundamentals Summary
| CMH fundamental statistics | |
|---|---|
| Market cap | kr27.82m |
| Earnings (TTM) | -kr29.19m |
| Revenue (TTM) | kr1.75m |
15.9x
P/S Ratio-1.0x
P/E RatioIs CMH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CMH income statement (TTM) | |
|---|---|
| Revenue | kr1.75m |
| Cost of Revenue | kr437.70k |
| Gross Profit | kr1.31m |
| Other Expenses | kr30.50m |
| Earnings | -kr29.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 24, 2024
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 74.94% |
| Net Profit Margin | -1,670.79% |
| Debt/Equity Ratio | 0% |
How did CMH perform over the long term?
See historical performance and comparison